FdaApplication
ANDA 205066
Identifiers
- fda_app_no: ANDA205066
Properties
| Property | Value |
|---|---|
| applicant_name | IMPAX LABORATORIES INC |
| application_type | ANDA |
| approval_date | 2018-06-29 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| RISEDRONATE SODIUM | RISEDRONATE SODIUM | 35MG | TABLET, DELAYED RELEASE;ORAL |
1 product